[go: up one dir, main page]

MX2010003703A - Composicion que comprende acidos grasos poliinsaturados y carbon activado. - Google Patents

Composicion que comprende acidos grasos poliinsaturados y carbon activado.

Info

Publication number
MX2010003703A
MX2010003703A MX2010003703A MX2010003703A MX2010003703A MX 2010003703 A MX2010003703 A MX 2010003703A MX 2010003703 A MX2010003703 A MX 2010003703A MX 2010003703 A MX2010003703 A MX 2010003703A MX 2010003703 A MX2010003703 A MX 2010003703A
Authority
MX
Mexico
Prior art keywords
fatty acids
polyunsaturated fatty
activated charcoal
composition
pufa
Prior art date
Application number
MX2010003703A
Other languages
English (en)
Inventor
Catherine Kabaradjian
Original Assignee
Bayer Consumer Care Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Consumer Care Ag filed Critical Bayer Consumer Care Ag
Publication of MX2010003703A publication Critical patent/MX2010003703A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a una composición oral sin mal olor ni olor o sabor que comprende ácidos grasos poliinsaturados (PUFA) y carbón activado, su proceso de fabricación y su uso como suplemento nutricional o como suplemento dietético para equilibrar el nivel lipídico sanguíneo, evitando o reduciendo el riesgo de desarrollo de cambios, trastornos o enfermedades ateroscleróticos.
MX2010003703A 2007-10-30 2008-10-21 Composicion que comprende acidos grasos poliinsaturados y carbon activado. MX2010003703A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07291306 2007-10-30
PCT/EP2008/008882 WO2009056247A1 (en) 2007-10-30 2008-10-21 Composition comprising polyunsaturated fatty acids and activated charcoal

Publications (1)

Publication Number Publication Date
MX2010003703A true MX2010003703A (es) 2010-07-30

Family

ID=40344798

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010003703A MX2010003703A (es) 2007-10-30 2008-10-21 Composicion que comprende acidos grasos poliinsaturados y carbon activado.

Country Status (15)

Country Link
US (1) US20100260893A1 (es)
EP (1) EP2214638B1 (es)
AR (1) AR070759A1 (es)
AT (1) ATE541560T1 (es)
AU (1) AU2008317920B2 (es)
BR (1) BRPI0818568A2 (es)
CA (1) CA2703816C (es)
ES (1) ES2379034T3 (es)
MX (1) MX2010003703A (es)
PE (1) PE20091076A1 (es)
PL (1) PL2214638T3 (es)
RU (1) RU2485940C2 (es)
TW (1) TW200942229A (es)
UY (1) UY31410A1 (es)
WO (1) WO2009056247A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9770047B2 (en) 2008-04-10 2017-09-26 U.S. Nutraceuticals, LLC Perilla seed composition
US9610313B2 (en) 2008-04-10 2017-04-04 U.S. Nutraceuticals Eye health composition and method using plant derived seed extract rich in essential fatty acids derived from perilla seed and carotenoids
US8784904B2 (en) 2008-04-10 2014-07-22 U.S. Nutraceuticals, LLC Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use
US8586104B2 (en) 2008-04-10 2013-11-19 U.S. Nutraceuticals, LLC Plant derived seed extract rich in essentially fatty acids derived from Salvia hispanica L. seed: composition of matter, manufacturing process and use
US20130108745A1 (en) * 2010-07-01 2013-05-02 Delante Health As Coated effervescent tablet
WO2013070856A1 (en) * 2011-11-09 2013-05-16 Denovo Inc. Toxin decontaminant food product and method of treating disorders of the gastrointestinal tract
RU2524358C2 (ru) * 2012-07-24 2014-07-27 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт питания РАМН" Российской академии медицинских наук (ФГБУ "НИИ питания" РАМН) Функциональный пищевой ингредиент с заданным липидным профилем
WO2014183108A1 (en) * 2013-05-10 2014-11-13 Nitromega Corp. Nutritional or dietary supplements containing fatty acids and nitrite
EA025006B1 (ru) * 2013-08-22 2016-11-30 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт питания РАМН" Российской академии медицинских наук (ФГБУ "НИИ питания" РАМН) Функциональный пищевой ингредиент с заданным липидным профилем
CN105935145B (zh) * 2015-12-18 2019-09-20 重庆两江药物研发中心有限公司 一种鱼油植物甾醇复合片剂及其制备方法
CN105919946B (zh) * 2016-05-31 2019-03-12 福格森（武汉）生物科技股份有限公司 一种dha微丸的制备方法
CN110087481A (zh) * 2016-12-15 2019-08-02 帝斯曼知识产权资产管理有限公司 包含硅酸盐和含具有至少20个碳原子的多不饱和脂肪酸(lc-pufa)的微生物细胞和/或植物细胞的共混物制剂
CN111067876B (zh) * 2019-12-04 2022-08-16 宁夏大学 一种α-亚麻酸双层片及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3702031A1 (de) 1987-01-24 1988-08-04 Basf Ag Verfahren zur herstellung von mikrodispersen fischoelpraeparaten
US5780039A (en) * 1992-04-23 1998-07-14 Novartis Nutrition Ag Orally-ingestible nutrition compositions having improved palatability
JPH0892587A (ja) 1994-09-22 1996-04-09 Baiotsukusu:Kk 魚臭のマスキング法
JP3534881B2 (ja) 1995-02-23 2004-06-07 太陽化学株式会社 乳化組成物
US6630192B2 (en) 1995-04-07 2003-10-07 Brandeis University Increasing the HDL level and the HDL/LDL ratio in human serum by balancing saturated and polyunsaturated dietary fatty acids
PL343902A1 (en) * 1997-02-21 2001-09-10 Abbott Lab Methods of and compositions for reducing enteritis and colitis morbidity rate
US6479545B1 (en) * 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
EP1155620B1 (en) * 2000-05-18 2005-08-10 Q-mega healthcare A/S Dietary supplement comprising vitamins, minerals and polyunsaturated fatty acids
JP2002204656A (ja) 2001-01-10 2002-07-23 Yakult Honsha Co Ltd 発酵乳飲食品及びその製造方法
DE20105126U1 (de) * 2001-03-23 2002-01-31 Bartz, Volker, 35440 Linden Fischöl zur oralen Einnahme
JP2004531399A (ja) * 2001-06-25 2004-10-14 ファルマシア・コーポレーション 圧縮コーティング錠剤を製造する方法および装置
EP1332759B1 (en) * 2002-02-04 2005-09-28 Kyowa Hakko Kogyo Co., Ltd. Pharmaceutical and nutritional compositions containing a di- or oligosaccharide as insulin secretion promoter
AU2003259904A1 (en) 2002-08-14 2004-03-03 E.I. Du Pont De Nemours And Company Coated polyunsaturated fatty acid-containing particles and coated liquid pharmaceutical-containing particles
CN100384548C (zh) * 2002-08-14 2008-04-30 索莱有限责任公司 具有高液体负载的固体易流动粉末
CN100438777C (zh) 2003-09-26 2008-12-03 雀巢技术公司 含有不饱和脂肪酸和微量元素的营养组合物
PT1566173E (pt) * 2004-02-20 2006-12-29 Udo Mattern Composição farmacêutica para aplicações orais e método para a preparar
US20060083786A1 (en) * 2004-07-29 2006-04-20 Glenmark Pharmaceuticals Limited Taste masking pharmaceutical composition containing levocetirizine
BRPI0614189A2 (pt) * 2005-08-03 2016-11-22 Sasol Tech Pty Ltd métodos para preparar um vaso muito grande para transporte e/ ou erguimento, para transportar um vaso muito grande e para erguer um vaso muito grande
GB0516069D0 (en) * 2005-08-04 2005-09-14 Imp College Innovations Ltd Pharmaceutical and use thereof

Also Published As

Publication number Publication date
EP2214638B1 (en) 2012-01-18
AU2008317920B2 (en) 2014-03-13
CA2703816A1 (en) 2009-05-07
RU2485940C2 (ru) 2013-06-27
US20100260893A1 (en) 2010-10-14
CA2703816C (en) 2016-07-19
AR070759A1 (es) 2010-05-05
RU2010121714A (ru) 2011-12-10
UY31410A1 (es) 2009-05-29
BRPI0818568A2 (pt) 2015-04-22
ES2379034T3 (es) 2012-04-20
WO2009056247A1 (en) 2009-05-07
AU2008317920A1 (en) 2009-05-07
EP2214638A1 (en) 2010-08-11
PL2214638T3 (pl) 2012-06-29
ATE541560T1 (de) 2012-02-15
PE20091076A1 (es) 2009-07-25
TW200942229A (en) 2009-10-16

Similar Documents

Publication Publication Date Title
MX2010003703A (es) Composicion que comprende acidos grasos poliinsaturados y carbon activado.
MX2010003843A (es) Composicion orodispersable que comprende acidos grasos poliinsaturados sin mal olor ni sabor.
MX2010005948A (es) Productos carnicos con niveles incrementados de acidos grasos beneficiosos.
EA201071206A1 (ru) Композиции, содержащие липид, и способы их применения
Schlörmann et al. In vitro fermentation of nuts results in the formation of butyrate and c 9, t 11 conjugated linoleic acid as chemopreventive metabolites
TW200744463A (en) Nutritional supplement containing long-chain polyunsaturated fatty acids
WO2009013596A3 (en) Fortification of nutritional products with olive extracts containing hydroxytyrosol and hydroxytyrosol fortified nutritional products
MX335992B (es) Composiciones de grasa solida que contiene un acido graso poliinsaturado y usos y produccion de las mismas.
BRPI0517776C8 (pt) composição de óleo de soja desodorizado, alvejado e refinado compreendendo ácido graxo poliinsaturado, bem como alimento, bebida, suplemento nutricional e óleo de cozinha compreendendo a referida composição
MX2011012375A (es) Extracto de semillas enteras de moriga sp y uso del mismo en composiciones cosmeticas y/o dermatologicas.
IN2014DN00208A (es)
WO2007107590A3 (en) Fad-2 mutants and high oleic plants
WO2006017627A3 (en) Dietary compositions comprising docosahexaenoic acid and eicosapentaenoic acid and use thereof for treating insulin resistance
WO2008018043A3 (en) Methods of improving bone health and muscle health
EA201070419A1 (ru) Состав для регулирования метаболизма липидов
WO2007100766A3 (en) Health bars and compositions for improving cardiovascular risk factors
BR112012007166A2 (pt) "composição de gordura alimentícia, método de uso de ácido estearidônico para formar uma composição de gordura alimentícia,composições alimentícias, manteiga de nozes e metodo para usar ácido esteardônico para formar uma manteiga de nozes.
WO2009037562A3 (en) Nutritional supplement formulations and fortified foods comprising such supplements
EP2506848A4 (en) SUBSTANCES TO REDUCE THE IMPACT OF HARD CARDIAL EVENTS CONTAINING AN EXTRACT OF RED FERMENTED RICE AND A MULTIPLE UNSATURATED OMEGA-3 FATTY ACID OR DERIVATIVES THEREOF
ATE547005T1 (de) Nährende speiseölzusammensetzungen und verfahren zu ihrer herstellung
MX2010006130A (es) Producto alimenticio que incluye uno o mas acidos grasos omega-3 y uno o mas sabores de fruta.
MX2009004339A (es) Alcoholes de acido graso.
MXPA04001129A (es) Mezclas de lipidos y productos de alimento que contienen acido graso oleico y acidos grasos omega-6, disenadas para incrementar el nivel intramiocelular de lipidos.
WO2008102017A3 (en) Food comprising polyunsaturated fatty acids for the prevention of chronic diseases
KR20150075055A (ko) 지방산의 균형을 갖추고 포화지방 함량이 낮은 식용유 조성물

Legal Events

Date Code Title Description
FG Grant or registration